Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Punam Malik

Showing results (81-90 of 102) with videos related to

Pageof 11
Sort By:
Blood|June 1, 2026
Renin-Angiotensin-Aldosterone System Inhibition Exacerbates Anemia in Sickle Cell DiseaseNajmeh Eskandari, Emma Pappano, Maria Armila D Ruiz, et al.
British Journal of Haematology|July 6, 2021
Early initiation of hydroxyurea (hydroxycarbamide) using individualised, pharmacokinetics-guided dosing can produce sustained and nearly pancellular expression of fetal haemoglobin in children with sickle cell anaemiaCharles T Quinn, Omar Niss, Min Dong, et al.
Scientific Reports|February 6, 2020
Left atrial dysfunction in sickle cell anemia is associated with diffuse myocardial fibrosis, increased right ventricular pressure and reduced exercise capacityTarek Alsaied, Omar Niss, Justin T Tretter, et al.
Scientific Reports|March 14, 2020
Author Correction: Left atrial dysfunction in sickle cell anemia is associated with diffuse myocardial fibrosis, increased right ventricular pressure and reduced exercise capacityTarek Alsaied, Omar Niss, Justin T Tretter, et al.
Blood Advances|April 6, 2026
Cure Sickle Cell Initiative Recommendations on Common Data Elements for Sickle Cell Disease Gene Therapy TrialsSophie Lanzkron, Victoria H Coleman-Cowger, Alexis A Thompson, et al.
Molecular Therapy. Methods & Clinical Development|October 11, 2016
Production and purification of high-titer foamy virus vector for the treatment of leukocyte adhesion deficiencyMd Nasimuzzaman, Danielle Lynn, Rebecca Ernst, et al.
Nature Communications|January 10, 2015
Vasculopathy-associated hyperangiotensinemia mobilizes haematopoietic stem cells/progenitors through endothelial AT₂R and cytoskeletal dysregulationKyung Hee Chang, Ramesh C Nayak, Swarnava Roy, et al.
Blood|May 5, 2025
A Novel Mouse Model of Hemoglobin SC Disease Reveals Mechanisms Underlying Beneficial Effects of HydroxyureaTahereh Setayesh, Mengna Chi, Zachery Oestreicher, et al.
Journal of Virology|October 20, 2017
Foamy Virus Vector Carries a Strong Insulator in Its Long Terminal Repeat Which Reduces Its Genotoxic PotentialMichael Aaron Goodman, Paritha Arumugam, Devin Marie Pillis, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 20, 2014
Perforin gene transfer into hematopoietic stem cells improves immune dysregulation in murine models of perforin deficiencyMarlene Carmo, Kimberly A Risma, Paritha Arumugam, et al.
Pageof 11

Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
Blood|June 1, 2026
Renin-Angiotensin-Aldosterone System Inhibition Exacerbates Anemia in Sickle Cell DiseaseNajmeh Eskandari, Emma Pappano, Maria Armila D Ruiz, et al.
British Journal of Haematology|July 6, 2021
Early initiation of hydroxyurea (hydroxycarbamide) using individualised, pharmacokinetics-guided dosing can produce sustained and nearly pancellular expression of fetal haemoglobin in children with sickle cell anaemiaCharles T Quinn, Omar Niss, Min Dong, et al.
Scientific Reports|February 6, 2020
Left atrial dysfunction in sickle cell anemia is associated with diffuse myocardial fibrosis, increased right ventricular pressure and reduced exercise capacityTarek Alsaied, Omar Niss, Justin T Tretter, et al.
Scientific Reports|March 14, 2020
Author Correction: Left atrial dysfunction in sickle cell anemia is associated with diffuse myocardial fibrosis, increased right ventricular pressure and reduced exercise capacityTarek Alsaied, Omar Niss, Justin T Tretter, et al.
Blood Advances|April 6, 2026
Cure Sickle Cell Initiative Recommendations on Common Data Elements for Sickle Cell Disease Gene Therapy TrialsSophie Lanzkron, Victoria H Coleman-Cowger, Alexis A Thompson, et al.
Molecular Therapy. Methods & Clinical Development|October 11, 2016
Production and purification of high-titer foamy virus vector for the treatment of leukocyte adhesion deficiencyMd Nasimuzzaman, Danielle Lynn, Rebecca Ernst, et al.
Nature Communications|January 10, 2015
Vasculopathy-associated hyperangiotensinemia mobilizes haematopoietic stem cells/progenitors through endothelial AT₂R and cytoskeletal dysregulationKyung Hee Chang, Ramesh C Nayak, Swarnava Roy, et al.
Blood|May 5, 2025
A Novel Mouse Model of Hemoglobin SC Disease Reveals Mechanisms Underlying Beneficial Effects of HydroxyureaTahereh Setayesh, Mengna Chi, Zachery Oestreicher, et al.
Journal of Virology|October 20, 2017
Foamy Virus Vector Carries a Strong Insulator in Its Long Terminal Repeat Which Reduces Its Genotoxic PotentialMichael Aaron Goodman, Paritha Arumugam, Devin Marie Pillis, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 20, 2014
Perforin gene transfer into hematopoietic stem cells improves immune dysregulation in murine models of perforin deficiencyMarlene Carmo, Kimberly A Risma, Paritha Arumugam, et al.
Pageof 11